1. Home
  2. LNTH vs CBT Comparison

LNTH vs CBT Comparison

Compare LNTH & CBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$63.31

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Logo Cabot Corporation

CBT

Cabot Corporation

HOLD

Current Price

$65.33

Market Cap

4.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
LNTH
CBT
Founded
1956
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
4.0B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
LNTH
CBT
Price
$63.31
$65.33
Analyst Decision
Buy
Hold
Analyst Count
6
3
Target Price
$74.17
$63.67
AVG Volume (30 Days)
1.1M
468.3K
Earning Date
11-06-2025
11-03-2025
Dividend Yield
N/A
2.76%
EPS Growth
N/A
N/A
EPS
2.39
6.02
Revenue
$1,525,933,000.00
$3,713,000,000.00
Revenue This Year
$0.01
N/A
Revenue Next Year
$1.24
$2.92
P/E Ratio
$26.45
$10.85
Revenue Growth
1.95
N/A
52 Week Low
$47.25
$58.33
52 Week High
$111.29
$108.93

Technical Indicators

Market Signals
Indicator
LNTH
CBT
Relative Strength Index (RSI) 71.16 54.67
Support Level $57.44 $61.78
Resistance Level $59.30 $65.62
Average True Range (ATR) 2.14 1.89
MACD 0.82 0.83
Stochastic Oscillator 91.35 96.02

Price Performance

Historical Comparison
LNTH
CBT

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

About CBT Cabot Corporation

Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.

Share on Social Networks: